ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Microarray Expression profiling
Scheme : Targeted Calls
Clear All
Filter by Field of Research
Epigenetics (incl. Genome Methylation and Epigenomics) (1)
Gene Expression (incl. Microarray and other genome-wide approaches) (1)
Neurogenetics (1)
Nutrition and Dietetics not elsewhere classified (1)
Other biomedical and clinical sciences not elsewhere classified (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (5)
Filter by Status
Closed (5)
Filter by Scheme
Targeted Calls (5)
Filter by Country
Australia (1)
Filter by Australian State/Territory
ACT (1)
VIC (1)
  • Researchers (0)
  • Funded Activities (5)
  • Organisations (30)
  • Funded Activity

    An Integrated Analysis Of Gene Expression And Chromosome Copy Number In Malignant Mesothelioma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $421,697.00
    Summary
    Mesothelioma is an aggressive, asbestos related cancer which causes more than 20,000 deaths worldwide per annum. Mesothelioma is characterised by a long latency between exposure to asbestos and development of the disease, estimated to be between 20 and 40 years. As such, the peak number of cases of mesothelioma is not expected in Australia until 2010, as asbestos use reached its peak in the 1970-80's. In 2010, deaths from mesothelioma will be more common than ovarian cancer and melanoma. This st .... Mesothelioma is an aggressive, asbestos related cancer which causes more than 20,000 deaths worldwide per annum. Mesothelioma is characterised by a long latency between exposure to asbestos and development of the disease, estimated to be between 20 and 40 years. As such, the peak number of cases of mesothelioma is not expected in Australia until 2010, as asbestos use reached its peak in the 1970-80's. In 2010, deaths from mesothelioma will be more common than ovarian cancer and melanoma. This study aims to explore the molecular defects that are involved in initiation and progression of mesothelioma. Using array comparative genomic hybridisation, a technique which allows comparison of the DNA of normal cells with that of cancer cells, we will classify chromosomal changes in the cancer cell and identify candidate genes which are involved in mesothelioma development.
    Read more Read less
    More information
    Funded Activity

    Disturbances Of DNA Regulation In Obesity, And Their Relationships To Metabolic Health

    Funder
    National Health and Medical Research Council
    Funding Amount
    $354,074.00
    Summary
    We have shown there exists significant differences in methylation patterns between Obese patients and healthy controls. In this study we will refine our understanding of the relationship between methylation and obesity. Our study will provide insight into how methylation changes observed in obesity influence downstream metabolic disorders such as diabetes and cardiovascular disease.
    More information
    Funded Activity

    Uncovering The Function Of Susceptibility Variants In Alzheimer's Disease: From GWAS To Cell-Type Specific EQTLs And MQTLs

    Funder
    National Health and Medical Research Council
    Funding Amount
    $647,804.00
    Summary
    This project will investigate some of the genetic and epigenetic changes that occur inside certain brain cells that make them selectively vulnerable to Alzheimer's disease, in order to better understand the mechsnisms that give origin to the disease and identify possible targets for precision therapies.
    More information
    Funded Activity

    Targeting G-quadruplex DNA As A Novel Therapeutic Strategy For Alzheimer’s And Frontotemporal Dementia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $720,144.00
    Summary
    Dementia is the third leading cause of death in Australia and there is an urgent need to identify new ways of treating diseases that cause dementia. Our research is focused on targeting an unusual DNA structure in Alzheimer’s and Frontotemporal dementia (FTD). We will use a precision-targeted technology to better control formation of this DNA structure in disease-causing genes, allowing us to switch off the gene and hence stop disease progression for Alzheimer’s and FTD.
    More information
    Funded Activity

    Early Nutrition, Epigenetics And Developmental Outcomes In Children.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $550,093.00
    Summary
    Increasing evidence demonstrates that early nutrition, including in pregnancy, has long lasting programming effects on later health of children. Evidence implicates epigenetics (literally ‘above DNA’) in mediating these effects. The most convincing data exists for obesity and related disorders such as metabolic syndrome, diabetes, and heart disease. The focus of this project is on understanding how ‘epigenetic’ mechanisms are influencing the way our genes function to cause these disorders.
    More information

    Showing 1-5 of 5 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback